Stock Price & Analysis

Based on the analysis of GL stock, the current price of $122.51 reflects a neutral technical position with mixed analyst sentiment. While the stock shows potential for upside due to positive earnings growth projections and a strong dividend increase, cautious optimism is advised due to mixed analyst ratings and potential risks.

Hold GL stock as the current price reflects fair value with potential for moderate upside.

Globe Life (GL) stock is projected to reach $136 by the end of 2025, driven by strong earnings growth and favorable mortality trends. The stock currently trades at $122.51, with a mean analyst price target of $136.50, reflecting optimism about its financial performance. Analysts highlight the company's 11% EPS growth projection and improving profitability as key drivers for the stock's upside.

The S1 support level for GL Stock is $121.76 ,The R1 resistant level for GL Stock is $129.62.

As of the end of day on 2025-03-14, the price of GL Stock was $122.99.

The target price for GL Stock according to analyst rating is 134.80, with the highest price target at 168.00 and the lowest at 115.00. Analysts have a Moderate Buy rating on GL Stock overall.

The market cap of GL is $10.5B.

Analysis and Insights

Globe Life Inc. (GL) appears to be fairly valued based on current metrics and market sentiment.

Valuation Analysis:

• PE Ratio: GL's PE ratio ranges from 7.44 to 11.12, indicating reasonable valuation compared to industry peers.
• EV/EBITDA: The ratio of 6.85 to 8.12 suggests moderate valuation without significant overpricing.
• Dividend Yield: At 0.87%, the yield is competitive, supported by a 12.5% dividend increase, reflecting confidence in cash flows.

Market Performance:

• GL has underperformed the S&P 500 over the past year but showed strength in 2025 with a 10.8% gain, outpacing the broader market.

Financial Performance:

• Mixed Q4 results with a 3.6% revenue increase and a 12.1% growth in non-GAAP net operating income, beating estimates.

Analyst Sentiment:

• A "Moderate Buy" consensus with a mean price target of $136.50, suggesting a 10.5% upside potential.

Conclusion:

GL is fairly valued with growth potential, supported by strong financials and dividend growth. However, market-wide valuations are high, so caution is advised.

Globe Life Inc. is an insurance holding company. The Company's primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, and intensive care products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare. It has four segments: life insurance, supplemental health insurance, annuities and investments. Life insurance segment’s products include traditional whole life and term life insurance.

Globe Life (GL) stock is predicted to reach $165 by 2030, driven by its strong position in the insurance market and growth in life and supplemental health insurance products. The stock is currently undervalued with a P/E ratio of 12.3, compared to its historical average, suggesting upside potential. Analysts expect continued profitability improvements and stable revenue growth to support the price target.

GL has a total of 3636 employees.